NCT00093470
Clinical Trial Information
Trial Number: NCT00093470 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission After Primary Induction Failure or Patients Over Age 60 in First Remission
Study ID:
E2902
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00093470-D3 | There are three submissions for PMID 34773794. This dataset, NCT00093470-D3, contains toxicity data reported during the first three cycles of treatment or the first three months post registration. Dataset NCT00093470-D1 contains baseline, treatment, and efficacy data. Dataset NCT00093470-D2 contains toxicity data reported on study. |
| NCT00093470-D2 | There are three submissions for PMID 34773794. This dataset, NCT00093470-D2 contains toxicity data reported on study. Dataset NCT00093470-D1 contains baseline, treatment, and efficacy data. Dataset NCT00093470-D3 contains toxicity data reported during the first three cycles of treatment or the first three months post registration. |
| NCT00093470-D1 | There are three submissions for PMID 34773794. This dataset, NCT00093470-D1, contains baseline, treatment, and efficacy data. Dataset NCT00093470-D2 contains toxicity data reported on study. Dataset NCT00093470-D3 contains toxicity data reported during the first three cycles of treatment or the first three months post registration. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®